Subbarao Venkata Yalla, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urodynamics | 49 | 2012 | 349 | 2.450 |
Why?
|
| Urinary Bladder | 52 | 2012 | 1155 | 1.930 |
Why?
|
| Urethra | 37 | 2015 | 406 | 1.790 |
Why?
|
| Urinary Bladder, Neurogenic | 18 | 2015 | 176 | 1.250 |
Why?
|
| Urinary Bladder Neck Obstruction | 18 | 2012 | 82 | 1.240 |
Why?
|
| Muscle, Smooth | 26 | 2012 | 931 | 1.140 |
Why?
|
| Urinary Incontinence | 15 | 2015 | 490 | 0.990 |
Why?
|
| Prostatic Hyperplasia | 12 | 2013 | 514 | 0.940 |
Why?
|
| Urination | 20 | 2000 | 204 | 0.890 |
Why?
|
| Muscle Contraction | 22 | 2012 | 1207 | 0.830 |
Why?
|
| Urination Disorders | 11 | 2002 | 236 | 0.820 |
Why?
|
| Urinary Catheterization | 13 | 2015 | 195 | 0.810 |
Why?
|
| Urinary Retention | 3 | 2015 | 100 | 0.670 |
Why?
|
| Spinal Cord Injuries | 16 | 2008 | 928 | 0.610 |
Why?
|
| Urinary Bladder, Overactive | 4 | 2012 | 117 | 0.580 |
Why?
|
| Urinary Incontinence, Stress | 6 | 2003 | 180 | 0.510 |
Why?
|
| Clitoris | 1 | 2015 | 35 | 0.500 |
Why?
|
| Prostatic Diseases | 4 | 2000 | 55 | 0.490 |
Why?
|
| Coitus | 1 | 2015 | 133 | 0.480 |
Why?
|
| Prostatism | 1 | 2013 | 16 | 0.420 |
Why?
|
| Electrosurgery | 1 | 2013 | 53 | 0.410 |
Why?
|
| Pressure | 28 | 2007 | 1170 | 0.400 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2013 | 77 | 0.400 |
Why?
|
| Caveolins | 1 | 2012 | 102 | 0.400 |
Why?
|
| Lasers, Solid-State | 1 | 2013 | 183 | 0.350 |
Why?
|
| Prostatectomy | 5 | 2003 | 1786 | 0.330 |
Why?
|
| Self Care | 1 | 2015 | 800 | 0.330 |
Why?
|
| Urinary Tract Infections | 5 | 2008 | 804 | 0.320 |
Why?
|
| Vaccinium macrocarpon | 1 | 2008 | 11 | 0.310 |
Why?
|
| Urine | 5 | 2008 | 363 | 0.270 |
Why?
|
| Caveolae | 3 | 2012 | 54 | 0.270 |
Why?
|
| Prostate | 4 | 2006 | 1758 | 0.250 |
Why?
|
| Urinary Bladder Diseases | 5 | 1997 | 166 | 0.240 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 2077 | 0.230 |
Why?
|
| Plant Extracts | 1 | 2008 | 493 | 0.230 |
Why?
|
| Penis | 6 | 2009 | 209 | 0.200 |
Why?
|
| Manometry | 2 | 2002 | 457 | 0.190 |
Why?
|
| Urinary Tract Physiological Phenomena | 2 | 1996 | 11 | 0.190 |
Why?
|
| Urethral Obstruction | 4 | 1998 | 56 | 0.190 |
Why?
|
| Isometric Contraction | 3 | 1996 | 149 | 0.180 |
Why?
|
| Urology | 6 | 2011 | 384 | 0.180 |
Why?
|
| Urethral Diseases | 5 | 1988 | 52 | 0.160 |
Why?
|
| Sensory Thresholds | 1 | 2000 | 377 | 0.160 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2003 | 589 | 0.160 |
Why?
|
| Male | 97 | 2015 | 363815 | 0.160 |
Why?
|
| DNA | 1 | 2012 | 7193 | 0.150 |
Why?
|
| Penile Diseases | 1 | 1998 | 47 | 0.150 |
Why?
|
| Ischemia | 4 | 2011 | 1901 | 0.140 |
Why?
|
| Aged | 57 | 2015 | 171163 | 0.140 |
Why?
|
| Abscess | 1 | 2000 | 605 | 0.130 |
Why?
|
| Bezoars | 1 | 1996 | 29 | 0.130 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 789 | 0.130 |
Why?
|
| Syncope | 1 | 1998 | 431 | 0.130 |
Why?
|
| Caveolin 1 | 3 | 2012 | 255 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2000 | 434 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 701 | 0.120 |
Why?
|
| Oxidative Stress | 4 | 2011 | 3140 | 0.120 |
Why?
|
| Dogs | 11 | 1999 | 3824 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11895 | 0.110 |
Why?
|
| Nerve Degeneration | 2 | 2009 | 748 | 0.110 |
Why?
|
| Candidiasis | 1 | 1996 | 372 | 0.110 |
Why?
|
| Rheology | 5 | 1998 | 347 | 0.100 |
Why?
|
| Receptors, Purinergic | 1 | 2012 | 66 | 0.100 |
Why?
|
| Cystoscopy | 3 | 2003 | 128 | 0.100 |
Why?
|
| Urologic Diseases | 3 | 1998 | 245 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 532 | 0.090 |
Why?
|
| Humans | 93 | 2015 | 765926 | 0.090 |
Why?
|
| Aged, 80 and over | 22 | 2015 | 59496 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2003 | 2176 | 0.090 |
Why?
|
| Middle Aged | 43 | 2015 | 223016 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1392 | 0.090 |
Why?
|
| Reflex | 4 | 1986 | 376 | 0.090 |
Why?
|
| Angiotensin II | 3 | 2007 | 844 | 0.090 |
Why?
|
| Impotence, Vasculogenic | 1 | 2009 | 13 | 0.080 |
Why?
|
| Urinary Tract | 3 | 2011 | 305 | 0.080 |
Why?
|
| Urethral Stricture | 3 | 1996 | 50 | 0.080 |
Why?
|
| Muscles | 4 | 1979 | 1577 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 1998 | 2188 | 0.080 |
Why?
|
| Spinal Cord Diseases | 1 | 1991 | 291 | 0.080 |
Why?
|
| Elasticity | 6 | 1991 | 652 | 0.080 |
Why?
|
| Proanthocyanidins | 1 | 2008 | 20 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 1996 | 1276 | 0.080 |
Why?
|
| Nursing Homes | 1 | 1996 | 1084 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 4044 | 0.070 |
Why?
|
| Catheters, Indwelling | 4 | 2003 | 436 | 0.070 |
Why?
|
| Compliance | 4 | 2007 | 100 | 0.070 |
Why?
|
| Aging | 6 | 2012 | 8725 | 0.070 |
Why?
|
| Microscopy, Electron | 8 | 2007 | 2543 | 0.070 |
Why?
|
| Societies, Medical | 2 | 1996 | 3953 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1966 | 0.070 |
Why?
|
| Ultrasound, High-Intensity Focused, Transrectal | 1 | 2006 | 6 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 8107 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2010 | 703 | 0.060 |
Why?
|
| Urothelium | 1 | 2008 | 275 | 0.060 |
Why?
|
| Digital Rectal Examination | 1 | 2006 | 42 | 0.060 |
Why?
|
| Models, Biological | 6 | 2004 | 9443 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 2476 | 0.060 |
Why?
|
| Cystitis | 2 | 1996 | 96 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 2000 | 1273 | 0.060 |
Why?
|
| Animals | 23 | 2015 | 168735 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2012 | 5019 | 0.060 |
Why?
|
| Adult | 33 | 2008 | 223088 | 0.060 |
Why?
|
| Trauma Severity Indices | 1 | 2006 | 479 | 0.060 |
Why?
|
| Placebos | 1 | 2008 | 1659 | 0.050 |
Why?
|
| Ataxia | 1 | 2006 | 307 | 0.050 |
Why?
|
| Rats | 4 | 2012 | 23708 | 0.050 |
Why?
|
| Prospective Studies | 12 | 2015 | 54807 | 0.050 |
Why?
|
| Ureteral Obstruction | 3 | 1993 | 293 | 0.050 |
Why?
|
| Female | 41 | 2015 | 396141 | 0.050 |
Why?
|
| Methods | 6 | 1980 | 1061 | 0.050 |
Why?
|
| Data Collection | 2 | 2006 | 3318 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2006 | 1587 | 0.050 |
Why?
|
| Diagnosis, Differential | 5 | 2000 | 12973 | 0.050 |
Why?
|
| Electric Stimulation | 6 | 2003 | 1738 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2108 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2015 | 8724 | 0.050 |
Why?
|
| Ureter | 2 | 2003 | 364 | 0.050 |
Why?
|
| Rabbits | 5 | 2010 | 4729 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2002 | 20133 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2261 | 0.040 |
Why?
|
| Atrophy | 1 | 2006 | 1629 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2015 | 65194 | 0.040 |
Why?
|
| Motor Neurons | 5 | 1988 | 871 | 0.040 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2000 | 142 | 0.040 |
Why?
|
| Caveolin 3 | 2 | 2012 | 24 | 0.040 |
Why?
|
| Caveolin 2 | 2 | 2012 | 25 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2006 | 5987 | 0.040 |
Why?
|
| Mitochondria | 2 | 2011 | 3669 | 0.040 |
Why?
|
| Pelvis | 1 | 1984 | 737 | 0.040 |
Why?
|
| Silicones | 1 | 2000 | 228 | 0.040 |
Why?
|
| Oxygen | 1 | 2011 | 4246 | 0.040 |
Why?
|
| Electromyography | 6 | 1990 | 1398 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1996 | 1607 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2000 | 14643 | 0.040 |
Why?
|
| Gels | 1 | 2000 | 420 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 2233 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 683 | 0.040 |
Why?
|
| Pelvic Neoplasms | 2 | 1984 | 248 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2003 | 736 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2003 | 15401 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1135 | 0.040 |
Why?
|
| Kidney Calculi | 2 | 1979 | 458 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1998 | 6321 | 0.040 |
Why?
|
| Viscosity | 2 | 2004 | 334 | 0.040 |
Why?
|
| Kidney | 2 | 2012 | 7073 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 2463 | 0.030 |
Why?
|
| Models, Structural | 1 | 1996 | 338 | 0.030 |
Why?
|
| Rupture, Spontaneous | 2 | 1996 | 360 | 0.030 |
Why?
|
| Diuresis | 1 | 1996 | 107 | 0.030 |
Why?
|
| Kidney Medulla | 2 | 1993 | 169 | 0.030 |
Why?
|
| Spasm | 1 | 1976 | 131 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2000 | 774 | 0.030 |
Why?
|
| Alcoholism | 1 | 2006 | 1978 | 0.030 |
Why?
|
| Vagina | 1 | 2000 | 849 | 0.030 |
Why?
|
| Testosterone | 1 | 2006 | 2495 | 0.030 |
Why?
|
| Neuromuscular Diseases | 3 | 1986 | 260 | 0.030 |
Why?
|
| Age Factors | 6 | 2012 | 18382 | 0.030 |
Why?
|
| Lipomatosis | 1 | 1975 | 112 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18292 | 0.030 |
Why?
|
| Sarcolemma | 1 | 1993 | 66 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12417 | 0.030 |
Why?
|
| Necrosis | 1 | 1998 | 1611 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 1998 | 834 | 0.030 |
Why?
|
| Emphysema | 1 | 1996 | 234 | 0.030 |
Why?
|
| Reference Values | 3 | 1996 | 4909 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1993 | 479 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1977 | 551 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 1993 | 198 | 0.030 |
Why?
|
| Television | 1 | 1996 | 409 | 0.030 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1993 | 163 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2012 | 150 | 0.030 |
Why?
|
| Linear Models | 2 | 2007 | 5873 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2012 | 189 | 0.020 |
Why?
|
| Phenylephrine | 2 | 2007 | 291 | 0.020 |
Why?
|
| Collagen | 2 | 1998 | 2616 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1974 | 225 | 0.020 |
Why?
|
| Electric Stimulation Therapy | 1 | 1998 | 634 | 0.020 |
Why?
|
| Fluorometry | 1 | 2011 | 99 | 0.020 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1975 | 335 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2012 | 23597 | 0.020 |
Why?
|
| Video Recording | 1 | 1996 | 977 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 275 | 0.020 |
Why?
|
| Radiography | 6 | 1985 | 6941 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2003 | 39228 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1973 | 433 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6202 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 684 | 0.020 |
Why?
|
| Transducers | 3 | 1976 | 238 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1996 | 1318 | 0.020 |
Why?
|
| Erectile Dysfunction | 3 | 1995 | 437 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2936 | 0.020 |
Why?
|
| Time Factors | 5 | 1998 | 40097 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7236 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2009 | 8530 | 0.020 |
Why?
|
| Losartan | 2 | 2003 | 263 | 0.020 |
Why?
|
| Urography | 3 | 1981 | 316 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12822 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1997 | 2141 | 0.020 |
Why?
|
| Dilatation | 3 | 1974 | 311 | 0.020 |
Why?
|
| Prevalence | 4 | 2001 | 15828 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 48 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1974 | 800 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2003 | 6360 | 0.020 |
Why?
|
| ROC Curve | 1 | 1995 | 3612 | 0.020 |
Why?
|
| Sodium | 1 | 1993 | 1591 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2596 | 0.020 |
Why?
|
| Latex | 1 | 2007 | 49 | 0.020 |
Why?
|
| Reflex, Abnormal | 1 | 1987 | 83 | 0.020 |
Why?
|
| Gene Expression | 2 | 2012 | 7581 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 214 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2007 | 66 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2007 | 75 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2007 | 229 | 0.020 |
Why?
|
| Bradykinin | 1 | 2007 | 205 | 0.020 |
Why?
|
| Carbachol | 1 | 2007 | 223 | 0.020 |
Why?
|
| Endoscopes | 1 | 1987 | 169 | 0.020 |
Why?
|
| Rest | 1 | 1991 | 940 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2007 | 155 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 932 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 1377 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1132 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1985 | 170 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 1993 | 2100 | 0.020 |
Why?
|
| Anesthesia, Local | 1 | 1987 | 276 | 0.010 |
Why?
|
| Hypogastric Plexus | 1 | 1984 | 16 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1985 | 175 | 0.010 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 1979 | 433 | 0.010 |
Why?
|
| Random Allocation | 1 | 2009 | 2394 | 0.010 |
Why?
|
| Electrodiagnosis | 1 | 1984 | 149 | 0.010 |
Why?
|
| Antioxidants | 1 | 2011 | 1671 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 653 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2007 | 677 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 11030 | 0.010 |
Why?
|
| Catheterization | 1 | 1988 | 1426 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 988 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2003 | 11090 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 1990 | 1422 | 0.010 |
Why?
|
| Serotonin | 1 | 2007 | 1046 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4959 | 0.010 |
Why?
|
| Clinical Protocols | 2 | 1997 | 1435 | 0.010 |
Why?
|
| Myosins | 1 | 2003 | 408 | 0.010 |
Why?
|
| Meningomyelocele | 1 | 2003 | 182 | 0.010 |
Why?
|
| Adolescent | 8 | 2003 | 88811 | 0.010 |
Why?
|
| Biopsy | 3 | 1997 | 6766 | 0.010 |
Why?
|
| Algorithms | 4 | 2007 | 14064 | 0.010 |
Why?
|
| Kinesics | 1 | 1979 | 13 | 0.010 |
Why?
|
| Postoperative Complications | 5 | 1984 | 15802 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1993 | 4909 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2012 | 81537 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 1984 | 706 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 1243 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 1670 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1996 | 22228 | 0.010 |
Why?
|
| Risk Factors | 2 | 2003 | 74850 | 0.010 |
Why?
|
| Physicians | 1 | 1996 | 4591 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1977 | 138 | 0.010 |
Why?
|
| Bacteriuria | 1 | 1978 | 102 | 0.010 |
Why?
|
| Pharmaceutic Aids | 1 | 1976 | 7 | 0.010 |
Why?
|
| Sheep | 1 | 2000 | 1445 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 261 | 0.010 |
Why?
|
| Diazepam | 1 | 1978 | 215 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1995 | 15878 | 0.010 |
Why?
|
| Anal Canal | 1 | 1979 | 376 | 0.010 |
Why?
|
| Bethanechol Compounds | 1 | 1976 | 10 | 0.010 |
Why?
|
| Citrates | 1 | 1976 | 130 | 0.010 |
Why?
|
| Percussion | 1 | 1976 | 17 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1984 | 3599 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4563 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1981 | 1818 | 0.010 |
Why?
|
| Penile Erection | 1 | 1995 | 100 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1978 | 3466 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1984 | 2248 | 0.010 |
Why?
|
| Seasons | 1 | 2001 | 1522 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2000 | 915 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 911 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1974 | 395 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1974 | 70 | 0.010 |
Why?
|
| Shock, Traumatic | 1 | 1973 | 22 | 0.010 |
Why?
|
| Castration | 1 | 1974 | 149 | 0.010 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1974 | 47 | 0.010 |
Why?
|
| Brain Diseases | 1 | 2003 | 1552 | 0.010 |
Why?
|
| Stomach Ulcer | 1 | 1974 | 118 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1973 | 82 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1993 | 3635 | 0.010 |
Why?
|
| Hernia | 1 | 1973 | 67 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 1975 | 274 | 0.010 |
Why?
|
| Elastic Tissue | 1 | 1973 | 65 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 5986 | 0.010 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 1993 | 106 | 0.010 |
Why?
|
| Ouabain | 1 | 1993 | 246 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1993 | 323 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20690 | 0.010 |
Why?
|
| Bumetanide | 1 | 1993 | 101 | 0.010 |
Why?
|
| Comorbidity | 2 | 1998 | 10575 | 0.010 |
Why?
|
| Kidney Pelvis | 1 | 1973 | 191 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2007 | 5088 | 0.010 |
Why?
|
| Furosemide | 1 | 1993 | 174 | 0.010 |
Why?
|
| Rupture | 1 | 1973 | 444 | 0.010 |
Why?
|
| Renal Artery | 1 | 1973 | 355 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1975 | 1142 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1993 | 562 | 0.010 |
Why?
|
| Sodium Channels | 1 | 1993 | 337 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1997 | 1060 | 0.010 |
Why?
|
| Child | 3 | 2003 | 80568 | 0.010 |
Why?
|
| Aneurysm | 1 | 1973 | 343 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1993 | 1643 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2001 | 2594 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1973 | 506 | 0.000 |
Why?
|
| Death | 1 | 1973 | 686 | 0.000 |
Why?
|
| NAD | 1 | 1993 | 618 | 0.000 |
Why?
|
| Biological Transport | 1 | 1993 | 2081 | 0.000 |
Why?
|
| Massachusetts | 1 | 2001 | 8882 | 0.000 |
Why?
|
| United States | 1 | 1996 | 72909 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1973 | 1216 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3716 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1995 | 2020 | 0.000 |
Why?
|
| Homes for the Aged | 1 | 1989 | 273 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1974 | 1793 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1993 | 1872 | 0.000 |
Why?
|
| Multiple Sclerosis | 1 | 1980 | 3212 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1995 | 4186 | 0.000 |
Why?
|
| Kinetics | 1 | 1993 | 6273 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1995 | 6251 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21513 | 0.000 |
Why?
|
| Metaplasia | 1 | 1977 | 325 | 0.000 |
Why?
|
| Quality of Life | 1 | 1998 | 13463 | 0.000 |
Why?
|
| Therapeutic Irrigation | 1 | 1976 | 297 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1973 | 5836 | 0.000 |
Why?
|
| Dementia | 1 | 1989 | 2741 | 0.000 |
Why?
|
| Tomography, X-Ray | 1 | 1973 | 58 | 0.000 |
Why?
|
| Neurologic Examination | 1 | 1974 | 913 | 0.000 |
Why?
|
| Testis | 1 | 1973 | 782 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1973 | 4882 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1973 | 4278 | 0.000 |
Why?
|
| Prognosis | 1 | 1973 | 29890 | 0.000 |
Why?
|